QA: ARTELO BIOSCIENCES INC. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001621221_2021_ARTELO_BIOSCIENCES_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001621221')"}

Graph

Absolute values for 0001621221, ARTELO BIOSCIENCES INC.

  xvar xval
0 AssetsCurrent 2,337,199
1 IntangibleAssetsNetIncludingGoodwill 2,039,417
2 PropertyPlantAndEquipmentNet 246
3 remainder_Assets 0
4 LiabilitiesCurrent 502,177
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,788,684
9 ResearchAndDevelopmentExpense 1,918,919
10 remainder_Expenses 978,172
11 remainder_Revenues 0
12 remainder_NetIncome 30,913
13 remainder_ComprehensiveNetIncome 73,568
  yvar yval
0 Assets 4,376,862
1 Liabilities 502,177
2 Expenses 4,685,775
3 Revenues 0
4 StockholdersEquity 3,874,685
5 NetIncome -4,654,862
6 ComprehensiveNetIncome -4,618,078
7 BaseVar 4,834,648
8 EconomicCapitalRatio 0.839

Edgar->Model Mapping

Feature Distribution

Change over Time